相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Anti-TIM3 Antibody Promotes T Cell IFN-γ-Mediated Antitumor Immunity and Suppresses Established Tumors
Shin Foong Ngiow et al.
CANCER RESEARCH (2011)
Impact of tumour volume on the potential efficacy of therapeutic vaccines
J. L. Gulley et al.
Current Oncology (2011)
The TNFR family members OX40 and CD27 link viral virulence to protective T cell vaccines in mice
Shahram Salek-Ardakani et al.
JOURNAL OF CLINICAL INVESTIGATION (2011)
4-1BB Signaling Synergizes with Programmed Death Ligand 1 Blockade To Augment CD8 T Cell Responses during Chronic Viral Infection
Vaiva Vezys et al.
JOURNAL OF IMMUNOLOGY (2011)
Targeting OX40 Promotes Lung-Resident Memory CD8 T Cell Populations That Protect against Respiratory Poxvirus Infection
Shahram Salek-Ardakani et al.
JOURNAL OF VIROLOGY (2011)
Chimeric Antigen Receptor-Modified T Cells in Chronic Lymphoid Leukemia
David L. Porter et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Immunomodulatory effects of cyclophosphamide and implementations for vaccine design
Antonella Sistigu et al.
SEMINARS IN IMMUNOPATHOLOGY (2011)
Control of Immunity by the TNFR-Related Molecule OX40 (CD134)
Michael Croft
ANNUAL REVIEW OF IMMUNOLOGY, VOL 28 (2010)
Adoptive T cell therapy of cancer
Malcolm K. Brenner et al.
CURRENT OPINION IN IMMUNOLOGY (2010)
OX40 is required for regulatory T cell-mediated control of colitis
Thibault Griseri et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2010)
OX40 Ligand Regulates Inflammation and Mortality in the Innate Immune Response to Sepsis
Matthew Karulf et al.
JOURNAL OF IMMUNOLOGY (2010)
Adjuvant Therapy With Agonistic Antibodies to CD134 (OX40) Increases Local Control After Surgical or Radiation Therapy of Cancer in Mice
Michael J. Gough et al.
JOURNAL OF IMMUNOTHERAPY (2010)
Enhanced Tumor Eradication by Combining CTLA-4 or PD-1 Blockade With CpG Therapy
Sara M. Mangsbo et al.
JOURNAL OF IMMUNOTHERAPY (2010)
Improved Survival with Ipilimumab in Patients with Metastatic Melanoma
F. Stephen Hodi et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Sipuleucel-T Immunotherapy for Castration-Resistant Prostate Cancer.
Philip W. Kantoff et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Immune Checkpoint Proteins: A New Therapeutic Paradigm for Cancer-Preclinical Background: CTLA-4 and PD-1 Blockade
Jeffrey Weber
SEMINARS IN ONCOLOGY (2010)
T-cell modulation combined with intratumoral CpG cures lymphoma in a mouse model without the need for chemotherapy
Roch Houot et al.
BLOOD (2009)
Synergistic OX40 and CD30 signals sustain CD8+ T cells during antigenic challenge
Vasileios Bekiaris et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2009)
Ligation of the OX40 co-stimulatory receptor reverses self-Ag and tumor-induced CD8 T-cell anergy in vivo
William L. Redmond et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2009)
OX40 engagement and chemotherapy combination provides potent antitumor immunity with concomitant regulatory T cell apoptosis
Daniel Hirschhorn-Cymerman et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2009)
Cutting Edge: OX40 Agonists Can Drive Regulatory T Cell Expansion if the Cytokine Milieu Is Right
Carl E. Ruby et al.
JOURNAL OF IMMUNOLOGY (2009)
Implications for KRAS status and EGFR-targeted therapies in metastatic CRC
Nicola Normanno et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2009)
OX40 agonist therapy enhances CD8 infiltration and decreases immune suppression in the tumor
Michael J. Gough et al.
CANCER RESEARCH (2008)
Multiple roles for CD4(+) T cells in anti-tumor immune responses
Richard Kennedy et al.
IMMUNOLOGICAL REVIEWS (2008)
Phase I study of recombinant interleukin-21 in patients with metastatic melanoma and renal cell carcinoma
John A. Thompson et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Self-Antigen Prevents CD8 T Cell Effector Differentiation by CD134 and CD137 Dual Costimulation
Suman Bandyopadhyay et al.
JOURNAL OF IMMUNOLOGY (2008)
IL-12 is required for anti-OX40-mediated CD4 T cell survival
Carl E. Ruby et al.
JOURNAL OF IMMUNOLOGY (2008)
OX40 Costimulatory Signals Potentiate the Memory Commitment of Effector CD8+ T Cells
Seyed Fazlollah Mousavi et al.
JOURNAL OF IMMUNOLOGY (2008)
OX40 Drives Protective Vaccinia Virus-Specific CD8 T Cells
Shahram Salek-Ardakani et al.
JOURNAL OF IMMUNOLOGY (2008)
Defects in the acquisition of CD8 T cell effector function after priming with tumor or soluble antigen can be overcome by the addition of an OX40 agonist
William L. Redmond et al.
JOURNAL OF IMMUNOLOGY (2007)
OX40 costimulation promotes persistence of cytomegalovirus-specific CD8 T cells: A CD4-dependent mechanism
Ian R. Humphreys et al.
JOURNAL OF IMMUNOLOGY (2007)
Development and characterization of recombinant human Fc:OX40L fusion protein linked via a coiled-coil trimerization domain
Nicholas P. Morris et al.
MOLECULAR IMMUNOLOGY (2007)
Immunostimulatory monoclonal antibodies for cancer therapy
Ignacio Melero et al.
NATURE REVIEWS CANCER (2007)
Anti-OX40 stimulation in vivo enhances CD8(+) memory T cell survival and significantly increases recall responses
Carl E. Ruby et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2007)
Targeting OX40 and OX40L for the treatment of Autoimmunity and cancer
William L. Redmond et al.
CRITICAL REVIEWS IN IMMUNOLOGY (2007)
Anti-OX40 (CD134) administration to nonhuman primates: Immunostimulatory effects and toxicokinetic study
Andrew D. Weinberg et al.
JOURNAL OF IMMUNOTHERAPY (2006)
The crystal structure of the costimulatory OX40-OX40L complex
Deanne M. Compaan et al.
STRUCTURE (2006)
IL-15 induces C4+ effector memory T cell production and tissue emigration in nonhuman primates
Louis J. Picker et al.
JOURNAL OF CLINICAL INVESTIGATION (2006)
Triggering of OX40 (CD134) on CD4+CD25+ T cells blocks their inhibitory activity:: a novel regulatory role for OX40 and its comparison with GITR
B Valzasina et al.
BLOOD (2005)
4-1BB and OX40 dual costimulation synergistically stimulate primary specific CD8 T cells for robust effector function
SJ Lee et al.
JOURNAL OF IMMUNOLOGY (2004)
Functional expression of CD134 by neutrophils
R Baumann et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2004)
Insufficient production and tissue delivery of CD4+ memory T cells in rapidly progressive simian immunodeficiency virus infection
LJ Picker et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2004)
Therapeutic targeting of the effector T-cell co-stimulatory molecule OX40
K Sugamura et al.
NATURE REVIEWS IMMUNOLOGY (2004)
History of antibody therapy for non-Hodgkin's lymphoma
A Forero et al.
SEMINARS IN ONCOLOGY (2003)
Ligation of OX40 (CD134) regulates graft-versus-host disease (GVHD) and graft rejection in allogeneic bone marrow transplant recipients
BR Blazar et al.
BLOOD (2003)
OX40-mediated memory T cell generation is TNF receptor-associated factor 2 dependent
RA Prell et al.
JOURNAL OF IMMUNOLOGY (2003)
Cancer regression and autoimmunity in patients after clonal repopulation with antitumor lymphocytes
ME Dudley et al.
SCIENCE (2002)
Constitutive OX40/OX40 ligand interaction induces autoimmune-like diseases
K Murata et al.
JOURNAL OF IMMUNOLOGY (2002)
OX40: targeted immunotherapy - implications for tempering autoimmunity and enhancing vaccines
AD Weinberg
TRENDS IN IMMUNOLOGY (2002)
Development and homeostasis of T cell memory in rhesus macaque
CJ Pitcher et al.
JOURNAL OF IMMUNOLOGY (2002)
Engagement of OX40 enhances antigen-specific CD4+ T cell mobilization/memory development and humoral immunity:: Comparison of αOX-40 with αCTLA-4
DE Evans et al.
JOURNAL OF IMMUNOLOGY (2001)
Augmentation versus inhibition: Effects of conjunctional OX-40 receptor monoclonal antibody and IL-2 treatment on adoptive immunotherapy of advanced tumor
J Kjaergaard et al.
JOURNAL OF IMMUNOLOGY (2001)
CD134L expression on dendritic cells in the mesenteric lymph nodes drives colitis in T cell-restored SCID mice
V Malmström et al.
JOURNAL OF IMMUNOLOGY (2001)
Amelioration of experimental autoimmune encephalomyelitis with Anti-OX40 ligand monoclonal antibody: A critical role for OX40 ligand in migration, but not development, of pathogenic T cells
C Nohara et al.
JOURNAL OF IMMUNOLOGY (2001)
Engagement of the OX-40 receptor in vivo enhances antitumor immunity
AD Weinberg et al.
JOURNAL OF IMMUNOLOGY (2000)
Danger and OX40 receptor signaling synergize to enhance memory T cell survival by inhibiting peripheral deletion
JR Maxwell et al.
JOURNAL OF IMMUNOLOGY (2000)
分享论文
